Kvaloy S - Search Results

1

High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.

Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S. Blystad A, et al. Among authors: kvaloy s. Bone Marrow Transplant. 1999 Oct;24(8):865-72. doi: 10.1038/sj.bmt.1701990. Bone Marrow Transplant. 1999. PMID: 10516698

2

Purging of tumor cells from leukapheresis products: experimental and clinical aspects.

Kvalheim G, Wang MY, Pharo A, Holte H, Jacobsen E, Beiske K, Kvaløy S, Smeland E, Funderud S, Fodstad O. Kvalheim G, et al. Among authors: kvaloy s. J Hematother. 1996 Aug;5(4):427-36. doi: 10.1089/scd.1.1996.5.427. J Hematother. 1996. PMID: 8877718 Review.

3

Immunomagnetic purging of lymphoma cells from autografts.

Kvalheim G, Holte H, Jakobsen E, Kvaloy S. Kvalheim G, et al. Among authors: kvaloy s. J Hematother. 1996 Oct;5(5):561-2. doi: 10.1089/scd.1.1996.5.561. J Hematother. 1996. PMID: 8938530

4

Bone-marrow MR imaging before and after autologous marrow transplantation in lymphoma patients without known bone-marrow involvement.

Lien HH, Blomlie V, Blystad AK, Holte H, Langholm R, Kvaløy S. Lien HH, et al. Among authors: kvaloy s. Acta Radiol. 1997 Sep;38(5):896-902. doi: 10.1080/02841859709172432. Acta Radiol. 1997. PMID: 9332252

5

Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.

Aurlien E, Holte H, Pharo A, Kvaløy S, Jakobsen E, Smeland EB, Kvalheim G. Aurlien E, et al. Among authors: kvaloy s. Bone Marrow Transplant. 1998 May;21(9):873-8. doi: 10.1038/sj.bmt.1701192. Bone Marrow Transplant. 1998. PMID: 9613778

6

Persistent changes in the immune system 4-10 years after ABMT.

Nordøy T, Kolstad A, Endresen P, Holte H, Kvaløy S, Kvalheim G, Husebekk A. Nordøy T, et al. Among authors: kvaloy s. Bone Marrow Transplant. 1999 Oct;24(8):873-8. doi: 10.1038/sj.bmt.1702006. Bone Marrow Transplant. 1999. PMID: 10516699

7

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.

Blystad AK, Enblad G, Kvaløy S, Berglund A, Delabie J, Holte H, Carlson K, Kvalheim G, Bengtsson M, Hagberg H. Blystad AK, et al. Among authors: kvaloy s. Bone Marrow Transplant. 2001 Apr;27(7):711-6. doi: 10.1038/sj.bmt.1702867. Bone Marrow Transplant. 2001. PMID: 11360110

8

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells.

Blystad AK, Holte H, Kvaløy S, Smeland E, Delabie J, Kvalheim G. Blystad AK, et al. Among authors: kvaloy s. Bone Marrow Transplant. 2001 Nov;28(9):849-57. doi: 10.1038/sj.bmt.1703244. Bone Marrow Transplant. 2001. PMID: 11781645 Free PMC article.

9

CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD.

Blystad AK, Torlakovic E, Holte H, Kvaløy S, Lenschow E, Kvalheim G. Blystad AK, et al. Among authors: kvaloy s. Cytotherapy. 2001;3(4):295-305. doi: 10.1080/146532401317070934. Cytotherapy. 2001. PMID: 12171718

10

Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.

Blystad AK, Delabie J, Kvaløy S, Holte H, Vålerhaugen H, Ikonomou I, Kvalheim G. Blystad AK, et al. Among authors: kvaloy s. Br J Haematol. 2004 Jun;125(5):605-12. doi: 10.1111/j.1365-2141.2004.04951.x. Br J Haematol. 2004. PMID: 15147376 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters